Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,465 | 391 | -2,397 | -828 | 956 |
| Depreciation Amortization | 111 | 626 | 519 | 401 | 266 |
| Accounts receivable | 11,920 | -2,648 | 5,397 | 4,898 | 8,683 |
| Accounts payable and accrued liabilities | -1,605 | 182 | -1,365 | -709 | -1,776 |
| Other Working Capital | 6,614 | 583 | 4,809 | 3,541 | 5,299 |
| Other Operating Activity | -9,274 | -1,126 | -8,986 | -9,662 | -12,868 |
| Operating Cash Flow | $2,301 | $-1,992 | $-2,023 | $-2,359 | $560 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -62 | -59 | -59 | -57 |
| Investing Cash Flow | $-2 | $-62 | $-59 | $-59 | $-57 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2,808 | 2,808 | 2,808 | N/A |
| Other Financing Activity | -498 | -917 | -627 | -383 | -135 |
| Financing Cash Flow | $-498 | $1,891 | $2,181 | $2,425 | $-135 |
| Beginning Cash Position | 578 | 741 | 741 | 741 | 741 |
| End Cash Position | 2,379 | 578 | 840 | 748 | 1,109 |
| Net Cash Flow | $1,801 | $-163 | $99 | $7 | $368 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,301 | -1,992 | -2,023 | -2,359 | 560 |
| Capital Expenditure | -2 | -62 | -59 | -59 | -57 |
| Free Cash Flow | 2,299 | -2,054 | -2,082 | -2,418 | 503 |